Fish oil rich in eicosapentaenoic acid protects against oxidative stress-related renal dysfunction induced by TCDD in Wistar rats
- 215 Downloads
Humans are systemically exposed to persistent organic pollutants, of which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has become a major environmental concern. Exposure to TCDD results in a wide variety of adverse health effects which is mediated by oxidative stress through CYP1A1 activation and arachidonic acid metabolites. Eicosapentaenoic acid (EPA) exhibits antioxidant property and competes with arachidonic acid in membrane phospholipids and produces anti-inflammatory EPA derivatives. Since both EPA and its derivatives have been reported to enhance the antioxidant mechanism, the present study aimed at studying whether EPA could offer protection against TCDD-induced oxidative stress and nephrotoxicity in Wistar rats. Estimation of kidney markers (serum urea and creatinine) and histopathological studies revealed that EPA treatment significantly reduced TCDD-induced renal damage. TCDD-induced oxidative damage was reflected in a significant increase in CYP1A1 activity and lipid peroxide levels with a concomitant decline in non-enzymic antioxidant (GSH) and various enzymic antioxidants such catalase (CAT), superoxide dismutase (SOD), glutathione-S-transferase (GST), and glutathione peroxidase (GPx). In addition, TCDD-induced oxidative stress also resulted in decline in Na+-K+ and Mg2+ATPases activities with increase in Ca2+ ATPases activity. Oral treatment with EPA showed a significant cytoprotection against TCDD-induced renal oxidative stress by decreased CYP1A1 activity and enhanced antioxidant status. TCDD-induced alterations in ATPase enzyme activities were also prevented by EPA treatment. Our results show clear evidence that EPA ameliorates TCDD-induced oxidative stress and kidney damage; thus suggest the potential of EPA as an effective therapeutic agent against toxic effects mediated through redox imbalance.
KeywordsCYP1A1 EPA Fish oil Oxidative stress TCDD
The author Kalaiselvi Palaniswamy gratefully acknowledges UGC-SAP RFSMS for the financial assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
- Bonting SL (1970) Sodium-potassium activated adenosine triphosphatase and cation transport. In: Bittar EE (ed) Membranes and ion transport. Wiley-Interscience, London, pp 257–263Google Scholar
- Carageorgiou H, Tzotzes V, Pantos C, Mourouzis C, Zarros A, Tsakiris S (2004) In vivo and in vitro effects of cadmium on adult rat brain total antioxidant status, acetylcholinesterase, (Na+, K+)-ATPase and Mg2 + -ATPase activities: protection by l-cysteine. Basic Clin Pharmacol 94:112–118CrossRefGoogle Scholar
- Fletcher N, Wahlstrom D, Lundberg R, Nilsson CB, Nilsson KC, Stockling K, Hellmold H, Hakansson H (2005) 2,3,7,8- Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol Appl Pharm 207:1–124CrossRefGoogle Scholar
- Hassoun E, Bagachi D, Stohs SJ (1996) TCDD, endrin and lindane induced increases in lipid metabolises in maternal sera and amniotic fluids of pregnant C57BL/6J and DBA/2J mice. Res Commun Mol Path 94:157–169Google Scholar
- IARC (1997) Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 69:1–631Google Scholar
- Kinehara M, Fukada I, Yoshida K, Ashida H (2009) High-throughput evaluation of aryl hydrocarbon receptor-binding sites selected via chromatin immuno precipitation based screening in Hepa-1c1c7 cells stimulated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Genes Genet Syst 83:455–468CrossRefGoogle Scholar
- Kopec AK, Burgoon LD, Ibrahim-Aibo D, Burg AR, Lee AW, Tashiro C, Potter D, Sharratt B, Harkema JR, Rowlands JC, Budinsky RA, Zacharewski TR (2010) Automated dose–response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF and PCB126 in C57BL/6 Mice. Toxicol Sci 118:286–297PubMedCentralPubMedCrossRefGoogle Scholar
- Peters AK, van Londen K, Bergman A, Bohonowych J, Denison MS, van den Berg M, Sanderson JT (2004) Effects of polybrominated diphenyl ethers on basal and TCDD-induced ethoxyresorufin activity and cytochrome P450-1A1 expression in MCF-7, HepG2, and H4IIE cells. Toxicol Sci 82:488–496PubMedCrossRefGoogle Scholar
- Peterson RE, Madhukar BV, Yang KH, Matsumura F (1979) Depression of adenosine triphosphatase activities in isolated liver surface membranes of 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats: correlation with effects on ouabain biliary excretion and bile flow. J Pharmacol Exp Ther 210:275–282PubMedGoogle Scholar
- Pohjanvirta R, Kuljn T, Morselt EL, Tuominen R, Juvonen R, Rpzman K, Mannisto P, Collan Y, Sainio EL, Tuomisto J (1989) Target tissue morphology and serum biochemistry following 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) exposure in a TCDD-susceptible and a TCDD-resistant rat strain. Fund Appl Toxicol 12:698–712CrossRefGoogle Scholar
- Therien AG, Blostein R (2000) Mechanisms of sodium pump regulation. Am J Physiol-Cell Ph 279:C541–566Google Scholar